This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $10,217.00 contract is for a maintenance agreement covering Molecular Devices' specialized bioanalytical instrumentation, software, and related services used in life sciences research, pharmaceutical development, and public health initiatives. As the original equipment manufacturer, Molecular...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Molecular Devices LLC, a manufacturer of bioanalytical measurement equipment. The $10,217.00 contract is for the maintenance of laboratory instruments, equipment, software, and related services. This contract does not have a set-aside designation. Molecular Devices LLC has a history of providing specialized...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for onsite performance assurance and one-time preventative maintenance service for the agency's Molecular Devices instruments. The contract has a ceiling value of $14,555.00 and an ultimate completion date of October 17, 2025. Molecular Devices LLC is a leading provider of bioanalytical...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Molecular Devices LLC, a division of Danaher Corporation. The $14,555.00 contract is for the provision of specialized laboratory equipment, software, and related services to support life sciences research, pharmaceutical development, and bioanalytical measurement. As the original equipment manufacturer, Molecular Devices LLC is...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a SPECTRAMAX ID3 SERVICE PLAN 1PM, ONSITE PERFORMANCE ASSURANCE with a ceiling value of $10,217.00 and a period of performance ending on October 31, 2025. The contract does not have a set-aside designation. Molecular Devices LLC is a leading provider of...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Molecular Devices LLC, a division of Danaher Corporation. The $24,732.09 contract is for the company's specialized laboratory instruments, equipment, software, and related services to enable life sciences research and drug discovery. As the original equipment manufacturer, Molecular Devices often receives...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The $57,545.00 contract is for a service agreement to provide laboratory equipment from Molecular Devices LLC, a division of Danaher Corporation. The contract does not have a set-aside designation and has an ultimate completion date of October 31, 2023. Molecular Devices LLC, as the...
This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Molecular Devices LLC, a for-profit limited liability company that manufactures bioanalytical measurement solutions. The $10,217.00 maintenance agreement contract does not have a set-aside designation and has a performance period ending on March 31, 2025. Molecular Devices has previously provided specialized laboratory...